Provided by Tiger Trade Technology Pte. Ltd.

Abbott Laboratories

103.17
+1.141.12%
Volume:1.20M
Turnover:123.71M
Market Cap:179.40B
PE:33.38
High:103.30
Open:101.65
Low:101.50
Close:102.03
52wk High:137.49
52wk Low:81.97
Shares:1.74B
Float Shares:1.70B
Volume Ratio:0.51
T/O Rate:0.07%
Dividend:2.48
Dividend Rate:2.40%
EPS(TTM):3.09
EPS(LYR):3.73
ROE:10.58%
ROA:5.33%
PB:3.51
PE(LYR):27.66

Loading ...

Abbott CEO Robert B. Ford Disposes of $ US 46.17 Million in Common Shares

Reuters
·
Aug 28

Agilent Technologies Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 28

Medtronic PLC Stock Underperforms Thursday When Compared to Competitors

Dow Jones
·
Aug 28

Abbott Laboratories' Stroke Treatment Device Receives CE Mark

MT Newswires Live
·
Aug 27

Abbott - to Expand Amulet 360 Use Across Europe in Coming Weeks

THOMSON REUTERS
·
Aug 27

Abbott - First European Cases Using Amulet 360 Completed in Germany and Denmark

THOMSON REUTERS
·
Aug 27

Abbott's Next-Generation Amulet 360™ Device Receives Ce Mark to Treat People with Atrial Fibrillation at Risk of Stroke

THOMSON REUTERS
·
Aug 27

Abbott Wins CE Mark for Amulet 360 Left Atrial Appendage Occluder in Europe

Reuters
·
Aug 27

Abbott Laboratories Stock Underperforms Wednesday When Compared to Competitors

Dow Jones
·
Aug 27

US Companies Face Rise in Cyber Attacks

Reuters
·
Aug 26

Piper Sandler Sticks to Their Buy Rating for Abbott Laboratories (ABT)

TIPRANKS
·
Aug 26

Perrigo Co. PLC Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 26

Abbott Laboratories Gets Regulatory Authorization for Dual Glucose-Ketone Sensor

MT Newswires Live
·
Aug 26

FDA Authorizes Abbott's Wearable to Monitor Ketone and Glucose in Diabetes Patients

Reuters
·
Aug 26

Abbott receives FDA authorization for Libre Duo 10 Day system

TIPRANKS
·
Aug 26

Abbott - to Launch Libre Duo 10 Day in U.S. Later This Year

THOMSON REUTERS
·
Aug 26

Abbott Receives FDA Authorization for World's First Dual Glucose-Ketone Sensing Technology for People with Diabetes

THOMSON REUTERS
·
Aug 26

FDA Authorizes First Wearable Device That Continuously Monitors Both Ketone Levels and Blood Sugar

Reuters
·
Aug 26

FDA :Granted Marketing Authorization to Abbott Diabetes Care for Libre Duo 10 Day Through De Novo Premarket Review Pathway

THOMSON REUTERS
·
Aug 26

Abbott Laboratories Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 22